Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Cameron John Marshall has worked on the following 75 EPO patent applications which have been published in the last five years:

EP11716449

METHOD FOR GENERATING A PARVOVIRUS B19 VIRUS-LIKE PARTICLE

IPC classification:
C07K 14/015, C12N 7/04
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11716129

BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 9/06, A61K 9/08, A61K 9/10, A61K 9/20, A61K 9/48, A61K 31/4375, A61P 31/12, A61P 37/04
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11738818

COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEINS

IPC classification:
A61K 39/095, A61P 31/04
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11736496

DELIVERY OF SELF-REPLICATING RNA USING BIODEGRADABLE POLYMER PARTICLES

IPC classification:
A61K 9/16, A61K 9/51, C12N 15/86, C12N 15/88
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11188902

Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use

IPC classification:
C12N 1/20, C12P 21/02
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11736498

DELIVERY OF RNA TO DIFFERENT CELL TYPES

IPC classification:
C12N 15/11, C12N 15/113
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Sarah Elizabeth Klaczynska, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11755497

SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/00, A61K 48/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP13166487

Targeted genomic modification with partially single-stranded donor molecules

IPC classification:
C07H 21/00, C07K 19/00, C12N 9/22, C12N 15/62, C12N 15/90
Agent:
Wolfgang Weiss, Weickmann & Weickmann PartmbB
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12713838

ENHANCED CELLULOSE DEGRADATION

IPC classification:
C11D 3/386, C12N 9/00, C12N 9/24, C12N 9/42, C13K 1/02
Applicant:
The Regents of the University of California
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12196378

Markers of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and methods of use thereof

IPC classification:
G01N 33/92
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12782478

GENETICALLY ENGINEERED MICROORGANISMS THAT METABOLIZE XYLOSE

IPC classification:
C12N 1/13, C12P 7/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12186937

Reverse genetics using non-endogenous POL I promoters

IPC classification:
C12N 15/85
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12727500

MICROBIAL METABOLISM OF CHLORINE OXYANIONS AS A CONTROL OF BIOGENIC HYDROGEN SULFIDE PRODUCTION

IPC classification:
C07K 14/195, C12N 1/00, C12N 15/63
Applicant:
The Regents of the University of California
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP12733249

UTILIZING A MULTIPHASE REACTOR FOR THE CONVERSION OF BIOMASS TO PRODUCE SUBSTITUTED FURANS

IPC classification:
C07D 307/46, C07D 307/50, C12P 17/04
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61K 39/155, A61P 31/14
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11712679

ADJUVANTED VACCINES FOR SEROGROUP B MENINGOCOCCUS

IPC classification:
A61K 39/00, C07K 14/22
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP11718982

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN -RELATED PROTEIN 6 (LRP6) ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46, C12N 15/113
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Daniela Deriu, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11723308

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN - RELATED PROTEIN 6 (LRP6) MULTIVALENT ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46, C12N 15/113
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Daniela Deriu, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12743037

COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

IPC classification:
C07K 14/005, C12Q 1/68, G01N 33/53
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13163405

Small animal model for HCV replication

IPC classification:
A01K 67/00, A01K 67/027, A61K 38/00
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722057

PRE-FUSION RSV F ANTIGENS

IPC classification:
C07K 14/135
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13185690

Vaccines including antigen from four strains of influenza virus

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12778013

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

IPC classification:
A61K 39/245, A61K 39/25, C12N 15/86
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP14150138

4-Methylpyrazole formulations

IPC classification:
A61K 9/48, A61K 31/415, A61P 25/32
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP11789700

SOLID DISPERSION COMPRISING TRIAZOLE COMPOUND

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/48, A61K 31/4196, A61K 31/4439, A61K 31/444, A61K 47/32, A61K 47/38, A61P 7/02, A61P 25/04, A61P 29/00, A61P 35/00, A61P 37/02, A61P 37/06
Applicant:
Astellas Pharma Inc.
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP12791061

IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

IPC classification:
A61K 39/21, A61K 39/385, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12735420

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/295, C07K 14/015, C07K 14/045
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 9/127, A61K 39/00
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 9/107, A61K 39/00, A61K 47/06, A61K 47/24
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12818607

ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS

IPC classification:
G01N 33/569
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12815957

ALGAL THERMOPLASTICS, THERMOSETS, PAPER, ADSORBANTS AND ABSORBANTS

IPC classification:
B01J 20/22, C08L 101/16, C12N 1/12
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP14160481

Alphavirus vectors for RSV and PIV vaccines

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/155, A61K 39/215, A61K 39/295, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12800536

METHODS OF PRODUCING CARBAMOYL PHOSPHATE AND UREA

IPC classification:
C02F 3/34, C02F 101/16, C07H 21/04, C12N 9/12, C12P 13/00, C12P 13/10, C12P 17/12
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12817789

CERTAIN KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

IPC classification:
A01N 43/54, C07D 239/42, C07D 471/04
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189933

Alphavirus vectors for influenza virus vaccines

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/12, A61K 39/145, A61K 39/155, A61K 39/215, A61K 39/295, C12N 15/86
Applicant:
Novartis Vaccines and Diagnostics Inc.
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Nicholas James Finnie, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12874745

METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS

IPC classification:
A61K 31/185, A61K 31/216
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
PATENT GRANTED
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION WITHDRAWN
EP13747515

VACCINES FOR SEROGROUP X MENINGOCOCCUS

IPC classification:
A61K 39/095
Applicant:
Novartis AG
Applicant:
Institut Pasteur
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13732536

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/21
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13745892

AUTO-ANTIGEN BIOMARKERS FOR LUPUS

IPC classification:
G01N 33/564
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13728300

POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF

IPC classification:
C07C 1/24, C07C 11/167, C07C 29/09, C07C 51/16, C07C 57/15, C07C 67/03, C07C 67/31, C07C 69/533, C07C 69/675, C07C 69/732
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP14192835

A variant form of urate oxidase and use thereof

IPC classification:
A61K 38/44, A61K 47/48, C12N 9/06, C12N 9/72
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13857455

METHODS OF ADMINISTERING AND EVALUATING NITROGEN SCAVENGING DRUGS FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY

IPC classification:
A61K 31/19, A61K 49/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
HGF Limited
Status:
EXAMINATION IN PROGRESS
EP11804867

FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

IPC classification:
G01N 33/537, G01N 33/569, G01N 33/68, G01N 33/84
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
The patent has been granted
EP15156612

Variant forms of urate oxidase and use thereof

IPC classification:
A61K 47/48, C12N 9/06
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Jonathan David Myers, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14714825

TOBACCO INBRED AND HYBRID PLANTS AND USES THEREOF

IPC classification:
A01H 5/12, C12N 9/10, C12N 15/82
Applicant:
North Carolina State University
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Simon Mark Kremer, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14769502

THIOESTERASES AND CELLS FOR PRODUCTION OF TAILORED OILS

IPC classification:
C12N 5/00, C12N 5/02, C12N 9/00, C12P 7/64
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11716647

AVIAN GROUP D ROTAVIRUS

IPC classification:
A61K 39/15, C07K 14/14
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14785518

PARALLELIZED SAMPLE HANDLING

IPC classification:
B81B 7/04
Applicant:
University of Chicago
Applicant:
California Institute of Technology
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11772782

CERTAIN AMINO-PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE

IPC classification:
A61K 31/506, A61K 31/519, A61P 21/00, C07D 401/12, C07D 401/14, C07D 413/14, C07D 417/14
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14813132

DELAYED RELEASE CYSTEAMINE BEAD FORMULATION

IPC classification:
A01N 33/08, A61K 9/32
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14814315

METHODS FOR ANALYZING CYSTEAMINE COMPOSITIONS

IPC classification:
B01D 15/32, G01N 21/33, G01N 30/04, G01N 30/16, G01N 30/34, G01N 30/89
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Anne Marie Carr, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14744940

A CARTRIDGE, CARTRIDGE READER AND METHOD FOR PREVENTING REUSE OF THE CARTRIDGE

IPC classification:
B01L 3/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11807233

MITOTIC KINESIN INHIBITORS FOR USE IN THE TREATMETNOF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/00, A61K 31/137, A61K 31/353, A61K 31/437, A61K 31/517, A61K 38/05, A61K 45/06, A61P 9/12, A61P 11/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13151551

Compositions and methods for use for antibodies against sclerostin

IPC classification:
A61K 31/663, A61K 39/00, A61K 39/395, A61K 45/06, C07K 16/18, C12N 15/13, C12N 15/63, G01N 33/68
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13164769

Improved methods for preparing squalene

IPC classification:
A61K 9/107, A61K 31/01, A61K 39/39, A61K 47/06, A61P 31/16, C07C 7/04, C07C 11/21
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11738802

IMPROVED METHODS FOR PREPARING SQUALENE

IPC classification:
A61K 9/107, A61K 39/00, A61K 39/145, A61K 39/39, A61K 47/06, B01D 3/10, C07C 7/04, C12N 7/00
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
PATENT MAINTAINED IN AMENDED FORM
EP14784356

LABELLING COMPOUNDS AND THEIR USE IN ASSAYS

IPC classification:
C07F 17/02, C12Q 1/68
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11805925

NOVEL FERROCENE LABELS FOR ELECTROCHEMICAL ASSAY AND THEIR USE IN ANALYTICAL METHODS

IPC classification:
C07F 17/02, C12Q 1/68, G01N 27/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11767067

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

IPC classification:
A61B 17/00, A61B 17/20, A61K 9/14, A61K 39/00, A61K 39/145, A61M 37/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11725975

INFLUENZA VIRUS REASSORTMENT METHOD

IPC classification:
A61K 39/145, C12N 7/02, C12N 15/113
Applicant:
Novartis AG
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11772778

CERTAIN AMINO-PYRIDAZINES, COMPOSITIONS THEREOF, AND METHODS OF THEIR USE

IPC classification:
A61K 31/50, C07D 237/20, C07D 237/24, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/06, C07D 405/14, C07D 409/14, C07D 411/04, C07D 413/04, C07D 413/14, C07D 417/14, C07D 487/04, C07D 487/10, C07D 513/04
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12198671

Vaccination with multiple clades of H5 influenza A virus

IPC classification:
A61K 39/145
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11787552

FOOD COMPOSITIONS COMPRISING TAILORED OILS

IPC classification:
A23D 9/00, C11B 5/00, C12P 7/64
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13157613

Hydrophilic filtration during manufacture of vaccine adjuvants

IPC classification:
A61K 9/107, A61K 39/12, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP11764862

GENERIC ASSAYS FOR DETECTION OF MAMMALIAN REOVIRUS

IPC classification:
C12Q 1/70
Applicant:
Novartis AG
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12741997

TAILORED OILS PRODUCED FROM RECOMBINANT OLEAGINOUS MICROORGANISMS

IPC classification:
C12N 1/13, C12N 9/02, C12N 9/10, C12N 9/16, C12N 15/52, C12P 7/64
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP15734548

HIGH-PROTEIN FOOD PRODUCTS MADE USING HIGH-PROTEIN MICROALGAE

IPC classification:
A23L 2/02, A23L 2/66, A23L 2/68, A23L 33/10, A23L 23/00
Agent:
Cameron John Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature